Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7771 USD | +10.86% | +5.01% | -84.16% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.09M |
---|---|---|---|---|---|
Net income 2024 * | -5M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.57
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 24.32% |
Latest transcript on Quoin Pharmaceuticals, Ltd.
1 day | +10.86% | ||
1 week | +5.01% | ||
1 month | +6.45% | ||
3 months | -71.95% | ||
6 months | -85.61% | ||
Current year | -84.16% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Myers
CEO | Chief Executive Officer | 62 | 18-03-04 |
Denise Carter
FOU | Founder | 55 | 18-03-04 |
Gordon Dunn
DFI | Director of Finance/CFO | 60 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Sember
BRD | Director/Board Member | - | 21-10-27 |
Dennis Langer
BRD | Director/Board Member | 73 | 21-10-27 |
Joseph Cooper
BRD | Director/Board Member | 66 | 21-10-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.7771 | +10.86% | 39,988 |
24-05-30 | 0.701 | +0.14% | 26,658 |
24-05-29 | 0.7 | -2.78% | 66,882 |
24-05-28 | 0.72 | -2.70% | 25,193 |
Delayed Quote Nasdaq, May 31, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.16% | 3.09M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- QNRX Stock